Compound Detail
CHEMBL1086218
VALSPODAR 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
C/C=C/C[C@@H](C)C(=O)[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C
Basic Information
| ChEMBL ID | CHEMBL1086218 |
| Name | VALSPODAR |
| Phase | Phase III |
| Structure Type | BOTH |
| InChI Key | YJDYDFNKCBANTM-QCWCSKBGSA-N |
6
Targets
15
Activities
3
Assay Types
4
PK Parameters
20
Publications
6
Known Names
20
Indications
1
Mechanisms
Molecular Properties
1214.7
MW (Da)
Drug Information
| Molecule Type | Protein |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| P-glycoprotein 1 inhibitor | INHIBITOR | ATP-dependent translocase ABCB1 | ✓ | ✓ |
Indications
Leukemia Leukemia, Basophilic, Acute Leukemia, Erythroblastic, Acute Leukemia, Megakaryoblastic, Acute Leukemia, Monocytic, Acute Leukemia, Myeloid, Acute Leukemia, Myeloid, Acute Leukemia, Myeloid, Acute Leukemia, Myelomonocytic, Acute Multiple Myeloma Myelodysplastic Syndromes Myeloproliferative Disorders Neoplasms, Plasma Cell Breast Neoplasms Carcinoma, Renal Cell Kidney Neoplasms Lymphoma Neoplasm Metastasis Neoplasms Ovarian Neoplasms
Activity Summary
IC50 9 meas. best 7.65
Ki 4 meas. best 6.87
EC50 2 meas. best 6.96
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| ATP-dependent translocase ABCB1 CHEMBL4302 | IC50 | 7.65 | 6.684 | 22.2 | 5 |
| Unchecked CHEMBL612545 | IC50 | 7.0 | 6.83 | 100.0 | 2 |
| ATP-dependent translocase ABCB1 CHEMBL4302 | EC50 | 6.96 | 6.675 | 110.0 | 2 |
| ATP-dependent translocase ABCB1 CHEMBL4302 | Ki | 6.87 | 6.38 | 134.0 | 2 |
| MDR CHEMBL614125 | IC50 | 4.84 | 4.84 | 14600.0 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 4.6 | 4.6 | 25300.0 | 1 |
| Multidrug resistance-associated protein 1 CHEMBL3004 | Ki | 4.57 | 4.57 | 27000.0 | 1 |
| ATP-binding cassette sub-family C member 2 CHEMBL5748 | Ki | 4.54 | 4.54 | 28900.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 2.6 | mL.min-1.kg-1 | Homo sapiens |
| Fu | 0.022 | - | Homo sapiens |
| MRT | 12.0 | hr | Homo sapiens |
| T1/2 | 10.0 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 18426954 | 10.1124/dmd.108.020479 | ADMET | 4 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 17045309 | 10.1016/j.neuropharm.2006.07.038 | ATP-dependent translocase ABCB1 | 4 |
| 9914792 | 10.1111/j.1349-7006.1998.tb00518.x | ATP-dependent translocase ABCB1 | 3 |
| 25215856 | 10.1021/np500385b | Unchecked | 3 |
| 9435299 | 10.1172/jci1269 | ATP-dependent translocase ABCB1 | 3 |
| 20014752 | 10.1021/tx900326k | Hepatotoxicity | 3 |
| - | 10.6019/CHEMBL4495565 | ADMET | 2 |
| - | 10.6019/CHEMBL4495565 | Vero C1008 | 2 |
| 10570049 | 10.1124/mol.56.6.1219 | ATP-binding cassette sub-family C member 2 | 2 |
| 9794919 | 10.1002/hep.510280523 | ATP-binding cassette sub-family C member 2 | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| 8862725 | 10.1097/00001813-199607000-00012 | ATP-dependent translocase ABCB1 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 22320402 | 10.1021/jm201121b | Unchecked | 2 |
| 8960059 | 10.1016/s0006-2952(96)00656-9 | ATP-dependent translocase ABCB1 | 1 |
| 9580581 | - | ATP-dependent translocase ABCB1 | 1 |
| 22452412 | 10.1021/jm201705f | ATP-dependent translocase ABCB1 | 1 |
| 11585759 | - | Multidrug resistance associated protein | 1 |
| 34606270 | 10.1021/acs.jmedchem.1c00779 | Broad substrate specificity ATP-binding cassette transporter ABCG2 | 1 |
Data from ChEMBL 36 via Core Engine